(Q38270427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1 reference

title

Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Augustinus B M Laudy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mark Rekers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Maarten H Moen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

21 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Sports Medicine

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

657-672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25416198%20AND%20SRC:MED&resulttype=core&format=json

OARSI-FDA initiative: defining the disease state of osteoarthritis

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Epidemiology of osteoarthritis and associated comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Osteoarthritis: epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

The role of growth factors in cartilage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

New treatments for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Joint pathology and platelet-rich plasma therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma: where are we now and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Best evidence synthesis: an intelligent alternative to meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Updated method guidelines for systematic reviews in the cochrane collaboration back review group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Sports medicine applications of platelet rich plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), K

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Patient-reported outcome measures (PROMs): how should I interpret reports of measurement properties? A practical guide for clinicians and researchers who are not biostatisticians

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Comparison of reliability and responsiveness of patient-reported clinical outcome measures in knee osteoarthritis rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma: a milieu of bioactive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma: from basic science to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036

Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJSPORTS-2014-094036